{
  "paper": {
    "doi": null,
    "pmcid": "PMC12784773",
    "title": "Ferroptosis\u2014The \"Double-Edged Sword\" in Cancer: Mechanisms of Tumor Suppression/Resistance and Therapeutic Manipulation",
    "authors": [],
    "journal": null,
    "year": null,
    "study_type": "narrative review",
    "eco_type": null
  },
  "extraction_provenance": {
    "extraction_pipeline": {
      "name": "medlit_pass1_extract",
      "version": "0.1.0",
      "git_commit": "39f1b7e43865f4ea820908097aed6859daeae7cf",
      "git_commit_short": "39f1b7e",
      "git_branch": "ingest-refactor",
      "git_dirty": true,
      "repo_url": "https://github.com/org/medlit"
    },
    "models": {
      "llm": {
        "name": "claude-sonnet-4-20250514",
        "version": ""
      }
    },
    "prompt": {
      "version": "v1",
      "template": "medlit_extraction_v1",
      "checksum": "sha256:f94cc0ab23940d18"
    },
    "execution": {
      "timestamp": "2026-02-23T18:24:24.505730Z",
      "hostname": "unknown",
      "python_version": "3.13.3",
      "duration_seconds": 40.46
    },
    "entity_resolution": null,
    "model_info": null
  },
  "entities": [
    {
      "id": "ferroptosis",
      "class": "Biological Process",
      "name": "ferroptosis",
      "synonyms": [
        "iron-dependent cell death",
        "ferroptotic cell death"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "cancer",
      "class": "Disease",
      "name": "cancer",
      "synonyms": [
        "malignancy",
        "tumor",
        "neoplasm"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "TP53",
      "class": "Gene",
      "name": "TP53",
      "synonyms": [
        "tumor protein 53",
        "p53"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:11998",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "SLC7A11",
      "class": "Gene",
      "name": "SLC7A11",
      "synonyms": [
        "cystine transporter solute carrier family 7 member 11"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:11059",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "GPX4",
      "class": "Gene",
      "name": "GPX4",
      "synonyms": [
        "glutathione peroxidase 4"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:4555",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "ACSL4",
      "class": "Gene",
      "name": "ACSL4",
      "synonyms": [
        "Acyl-CoA Synthetase Long Chain Family Member 4"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:3571",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "FSP1",
      "class": "Gene",
      "name": "FSP1",
      "synonyms": [
        "Ferroptosis suppressor protein 1",
        "AIFM2"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:16686",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "erastin",
      "class": "Drug",
      "name": "erastin",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "RSL3",
      "class": "Drug",
      "name": "RSL3",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "sorafenib",
      "class": "Drug",
      "name": "sorafenib",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": "608804",
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "hepatocellular_carcinoma",
      "class": "Disease",
      "name": "hepatocellular carcinoma",
      "synonyms": [
        "HCC"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "pancreatic_ductal_adenocarcinoma",
      "class": "Disease",
      "name": "pancreatic ductal adenocarcinoma",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "triple_negative_breast_cancer",
      "class": "Disease",
      "name": "triple-negative breast cancer",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "clear_cell_renal_cell_carcinoma",
      "class": "Disease",
      "name": "clear cell renal cell carcinoma",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "ROS",
      "class": "Chemical",
      "name": "reactive oxygen species",
      "synonyms": [
        "ROS"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "iron",
      "class": "Chemical",
      "name": "iron",
      "synonyms": [
        "Fe"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "glutathione",
      "class": "Chemical",
      "name": "glutathione",
      "synonyms": [
        "GSH"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "lipid_peroxidation",
      "class": "Biological Process",
      "name": "lipid peroxidation",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "NRF2",
      "class": "Gene",
      "name": "NRF2",
      "synonyms": [
        "Nuclear factor (erythroid-derived 2)-like 2"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:7782",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "KEAP1",
      "class": "Gene",
      "name": "KEAP1",
      "synonyms": [
        "kelch-like ECH-associated protein 1"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:23177",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    }
  ],
  "evidence_entities": [
    {
      "id": "paper_1:introduction:1:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "paper_1",
      "text_span_id": "intro_1",
      "text": "Ferroptosis is an iron-dependent form of programmed cell death that is driven by the accumulation of reactive oxygen species (ROS), leading to the formation of membrane-damaging lipid peroxides",
      "confidence": 0.95,
      "extraction_method": "llm",
      "study_type": "narrative review",
      "eco_type": null,
      "source": "extracted"
    },
    {
      "id": "paper_1:introduction:2:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "paper_1",
      "text_span_id": "intro_2",
      "text": "The manipulation of ferroptosis has become an attractive area of cancer research, as both the promotion and inhibition of this form of cell death have been seen to positively affect cancer outcomes",
      "confidence": 0.9,
      "extraction_method": "llm",
      "study_type": "narrative review",
      "eco_type": null,
      "source": "extracted"
    },
    {
      "id": "paper_1:mechanisms:1:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "paper_1",
      "text_span_id": "mech_1",
      "text": "TP53 is the most frequently mutated tumor-suppressor gene and can play an important role in the promotion of ferroptosis in cancer. It downregulates SLC7A11 expression, a key component of the xCT system",
      "confidence": 0.95,
      "extraction_method": "llm",
      "study_type": "narrative review",
      "eco_type": null,
      "source": "extracted"
    },
    {
      "id": "paper_1:therapeutics:1:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "paper_1",
      "text_span_id": "ther_1",
      "text": "Erastin acts through the inhibition of the xCT antiporter composed of both SLC7A11 and SLC3A2. Inhibition of this antiporter leads to decreased intracellular cystine uptake and subsequent depletion of GSH",
      "confidence": 0.95,
      "extraction_method": "llm",
      "study_type": "narrative review",
      "eco_type": null,
      "source": "extracted"
    },
    {
      "id": "paper_1:therapeutics:2:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "paper_1",
      "text_span_id": "ther_2",
      "text": "RSL3 is another induction molecule that directly inhibits GPX4 by bypassing the need for GSH depletion",
      "confidence": 0.95,
      "extraction_method": "llm",
      "study_type": "narrative review",
      "eco_type": null,
      "source": "extracted"
    },
    {
      "id": "paper_1:therapeutics:3:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "paper_1",
      "text_span_id": "ther_3",
      "text": "An HCC study has shown that sorafenib enhances ferroptosis through the inhibition of SLC7A11 and subsequent decrease in cystine uptake",
      "confidence": 0.9,
      "extraction_method": "llm",
      "study_type": "narrative review",
      "eco_type": null,
      "source": "extracted"
    }
  ],
  "relationships": [
    {
      "subject": "ferroptosis",
      "predicate": "ASSOCIATED_WITH",
      "object": "cancer",
      "evidence_ids": [
        "paper_1:introduction:2:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.9,
      "properties": {
        "relationship_type": "bidirectional"
      },
      "section": "introduction",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "TP53",
      "predicate": "REGULATES",
      "object": "SLC7A11",
      "evidence_ids": [
        "paper_1:mechanisms:1:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.95,
      "properties": {
        "regulation_type": "downregulation"
      },
      "section": "mechanisms",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "TP53",
      "predicate": "PROMOTES",
      "object": "ferroptosis",
      "evidence_ids": [
        "paper_1:mechanisms:1:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.95,
      "properties": {},
      "section": "mechanisms",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "erastin",
      "predicate": "INHIBITS",
      "object": "SLC7A11",
      "evidence_ids": [
        "paper_1:therapeutics:1:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.95,
      "properties": {
        "mechanism": "xCT antiporter inhibition"
      },
      "section": "therapeutics",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "erastin",
      "predicate": "INDUCES",
      "object": "ferroptosis",
      "evidence_ids": [
        "paper_1:therapeutics:1:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.95,
      "properties": {
        "mechanism": "GSH depletion"
      },
      "section": "therapeutics",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "RSL3",
      "predicate": "INHIBITS",
      "object": "GPX4",
      "evidence_ids": [
        "paper_1:therapeutics:2:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.95,
      "properties": {
        "mechanism": "direct inhibition"
      },
      "section": "therapeutics",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "RSL3",
      "predicate": "INDUCES",
      "object": "ferroptosis",
      "evidence_ids": [
        "paper_1:therapeutics:2:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.95,
      "properties": {},
      "section": "therapeutics",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "sorafenib",
      "predicate": "TREATS",
      "object": "hepatocellular_carcinoma",
      "evidence_ids": [
        "paper_1:therapeutics:3:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.9,
      "properties": {
        "mechanism": "ferroptosis induction"
      },
      "section": "therapeutics",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "sorafenib",
      "predicate": "INHIBITS",
      "object": "SLC7A11",
      "evidence_ids": [
        "paper_1:therapeutics:3:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.9,
      "properties": {},
      "section": "therapeutics",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "iron",
      "predicate": "REQUIRED_FOR",
      "object": "ferroptosis",
      "evidence_ids": [
        "paper_1:introduction:1:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.95,
      "properties": {},
      "section": "introduction",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "ROS",
      "predicate": "CAUSES",
      "object": "lipid_peroxidation",
      "evidence_ids": [
        "paper_1:introduction:1:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.95,
      "properties": {},
      "section": "introduction",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "lipid_peroxidation",
      "predicate": "LEADS_TO",
      "object": "ferroptosis",
      "evidence_ids": [
        "paper_1:introduction:1:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.95,
      "properties": {},
      "section": "introduction",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    }
  ],
  "notes": [
    "This paper presents ferroptosis as having a dual role in cancer - both tumor suppressive and tumor promoting depending on context",
    "Multiple therapeutic approaches are discussed including ferroptosis induction and inhibition strategies",
    "The paper emphasizes the importance of understanding tumor microenvironment and immune system interactions with ferroptosis"
  ]
}